2021 EFAS/AAS/EAN共识声明：在可能导致短暂意识丧失情况下进行倾斜试验和其他激发性心血管自主神经测试建议

2021-03-19 Clin Auton Res . 2021 Mar 19.

2021年3月，欧洲自主神经联合会(EFAS)联合美国自主神经科学学会(AAS)、欧洲神经病学学会(EAN)共同发布了在可能导致短暂意识丧失情况下进行倾斜试验和其他激发性心血管自主神经测试的共识建议。

中文标题：

英文标题：

Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness

发布机构：

发布日期：

2021-03-19

简要介绍：

2021年3月，欧洲自主神经联合会(EFAS)联合美国自主神经科学学会(AAS)、欧洲神经病学学会(EAN)共同发布了在可能导致短暂意识丧失情况下进行倾斜试验和其他激发性心血管自主神经测试的共识建议。本文主要针对在可能导致短暂性意识丧失的情况下使用倾斜试验诊断疾病提供指导，同时介绍了何时需要其他刺激性心血管自主神经测试。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=ee8ab1c0020e8298, title=2021 EFAS/AAS/EAN共识声明：在可能导致短暂意识丧失情况下进行倾斜试验和其他激发性心血管自主神经测试建议, enTitle=Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness, guiderFrom=Clin Auton Res . 2021 Mar 19. , authorId=0, author=, summary=2021年3月，欧洲自主神经联合会(EFAS)联合美国自主神经科学学会(AAS)、欧洲神经病学学会(EAN)共同发布了在可能导致短暂意识丧失情况下进行倾斜试验和其他激发性心血管自主神经测试的共识建议。, cover=https://img.medsci.cn/2021331/1617120332399_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Mar 19 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年3月，欧洲自主神经联合会(EFAS)联合美国自主神经科学学会(AAS)、欧洲神经病学学会(EAN)共同发布了在可能导致短暂意识丧失情况下进行倾斜试验和其他激发性心血管自主神经测试的共识建议。本文主要针对在可能导致短暂性意识丧失的情况下使用倾斜试验诊断疾病提供指导，同时介绍了何时需要其他刺激性心血管自主神经测试。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=30354, tagName=意识丧失)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=30354, guiderKeyword=意识丧失, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=29382, appHits=120, showAppHits=0, pcHits=538, showPcHits=29262, likes=1, shares=9, comments=12, approvalStatus=1, publishedTime=Wed Mar 31 00:05:49 CST 2021, publishedTimeString=2021-03-19, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Wed Mar 31 00:05:41 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 19:27:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=丧失情况下进行倾斜试验和其他激发性心血管自主神经测试建议.pdf)])

丧失情况下进行倾斜试验和其他激发性心血管自主神经测试建议.pdf

下载请点击：

评论区 (11)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=959459, encodeId=1b7a959459ec, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 22 18:10:28 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956769, encodeId=7785956e69c8, content=三人行，必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入，添加【梅斯医学科研助手WeChat：medsci_2021】邀您进群！【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。【入群福利】👉 群内可实时交流病例，提问同行，跨群讨论，每天更新前沿医学资讯和指南共识，每周推出至少1场专业直播，不时共享科研干货，入群即可获得100份SCI写作攻略！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Wed Apr 14 00:17:17 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954197, encodeId=877d95419ecd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/7bc23eec272e4164811f9db8c32bd6d0/224de44e1ed644e5b3a11a9ae2d4e078.jpg, createdBy=9d1c5453900, createdName=ms2000001864293950, createdTime=Tue Apr 06 13:54:05 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953359, encodeId=46689533598c, content=这是非常好的一个题目。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1815461616, createdName=冯周琴，, createdTime=Fri Apr 02 19:44:56 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953093, encodeId=f1a09530933b, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 01 16:10:27 CST 2021, time=2021-04-01, status=1, ipAttribution=)]
2021-04-22 jyzxjiangqin

好共识！

70 0
[GetPortalCommentsPageByObjectIdResponse(id=959459, encodeId=1b7a959459ec, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 22 18:10:28 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956769, encodeId=7785956e69c8, content=三人行，必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入，添加【梅斯医学科研助手WeChat：medsci_2021】邀您进群！【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。【入群福利】👉 群内可实时交流病例，提问同行，跨群讨论，每天更新前沿医学资讯和指南共识，每周推出至少1场专业直播，不时共享科研干货，入群即可获得100份SCI写作攻略！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Wed Apr 14 00:17:17 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954197, encodeId=877d95419ecd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/7bc23eec272e4164811f9db8c32bd6d0/224de44e1ed644e5b3a11a9ae2d4e078.jpg, createdBy=9d1c5453900, createdName=ms2000001864293950, createdTime=Tue Apr 06 13:54:05 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953359, encodeId=46689533598c, content=这是非常好的一个题目。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1815461616, createdName=冯周琴，, createdTime=Fri Apr 02 19:44:56 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953093, encodeId=f1a09530933b, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 01 16:10:27 CST 2021, time=2021-04-01, status=1, ipAttribution=)]
2021-04-14 梅干儿

三人行，必有我师。 #梅斯医学科研互助群# 欢迎您的加入，添加【梅斯医学科研助手WeChat：medsci_2021】邀您进群！【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。【入群福利】👉 群内可实时交流病例，提问同行，跨群讨论，每天更新前沿医学资讯和指南共识，每周推出至少1场专业直播，不时共享科研干货，入群即可获得100份SCI写作攻略！

69 0
[GetPortalCommentsPageByObjectIdResponse(id=959459, encodeId=1b7a959459ec, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 22 18:10:28 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956769, encodeId=7785956e69c8, content=三人行，必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入，添加【梅斯医学科研助手WeChat：medsci_2021】邀您进群！【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。【入群福利】👉 群内可实时交流病例，提问同行，跨群讨论，每天更新前沿医学资讯和指南共识，每周推出至少1场专业直播，不时共享科研干货，入群即可获得100份SCI写作攻略！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Wed Apr 14 00:17:17 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954197, encodeId=877d95419ecd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/7bc23eec272e4164811f9db8c32bd6d0/224de44e1ed644e5b3a11a9ae2d4e078.jpg, createdBy=9d1c5453900, createdName=ms2000001864293950, createdTime=Tue Apr 06 13:54:05 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953359, encodeId=46689533598c, content=这是非常好的一个题目。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1815461616, createdName=冯周琴，, createdTime=Fri Apr 02 19:44:56 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953093, encodeId=f1a09530933b, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 01 16:10:27 CST 2021, time=2021-04-01, status=1, ipAttribution=)]
2021-04-06 ms2000001864293950

学习了

84 0
[GetPortalCommentsPageByObjectIdResponse(id=959459, encodeId=1b7a959459ec, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 22 18:10:28 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956769, encodeId=7785956e69c8, content=三人行，必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入，添加【梅斯医学科研助手WeChat：medsci_2021】邀您进群！【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。【入群福利】👉 群内可实时交流病例，提问同行，跨群讨论，每天更新前沿医学资讯和指南共识，每周推出至少1场专业直播，不时共享科研干货，入群即可获得100份SCI写作攻略！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Wed Apr 14 00:17:17 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954197, encodeId=877d95419ecd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/7bc23eec272e4164811f9db8c32bd6d0/224de44e1ed644e5b3a11a9ae2d4e078.jpg, createdBy=9d1c5453900, createdName=ms2000001864293950, createdTime=Tue Apr 06 13:54:05 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953359, encodeId=46689533598c, content=这是非常好的一个题目。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1815461616, createdName=冯周琴，, createdTime=Fri Apr 02 19:44:56 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953093, encodeId=f1a09530933b, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 01 16:10:27 CST 2021, time=2021-04-01, status=1, ipAttribution=)]
2021-04-02 冯周琴，

这是非常好的一个题目。

88 0
[GetPortalCommentsPageByObjectIdResponse(id=959459, encodeId=1b7a959459ec, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 22 18:10:28 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956769, encodeId=7785956e69c8, content=三人行，必有我师。 <a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a> 欢迎您的加入，添加【梅斯医学科研助手WeChat：medsci_2021】邀您进群！【社群简介】👉 梅斯医学目前已建立覆盖肿瘤、心血管、神经、消化、内分泌、呼吸等30个科室的学习交流社群。【入群福利】👉 群内可实时交流病例，提问同行，跨群讨论，每天更新前沿医学资讯和指南共识，每周推出至少1场专业直播，不时共享科研干货，入群即可获得100份SCI写作攻略！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210413/08ec7710e47c4f6dba6c277207bf00ec/823f09e953ea44188e56b38cd2f16334.jpg, createdBy=ec565230154, createdName=梅干儿, createdTime=Wed Apr 14 00:17:17 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954197, encodeId=877d95419ecd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210601/7bc23eec272e4164811f9db8c32bd6d0/224de44e1ed644e5b3a11a9ae2d4e078.jpg, createdBy=9d1c5453900, createdName=ms2000001864293950, createdTime=Tue Apr 06 13:54:05 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953359, encodeId=46689533598c, content=这是非常好的一个题目。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1815461616, createdName=冯周琴，, createdTime=Fri Apr 02 19:44:56 CST 2021, time=2021-04-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953093, encodeId=f1a09530933b, content=好共识！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Apr 01 16:10:27 CST 2021, time=2021-04-01, status=1, ipAttribution=)]
2021-04-01 jyzxjiangqin

好共识！

106 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

2021 EFAS/AAS/EAN共识声明：在可能导致短暂意识丧失情况下进行倾斜试验和其他激发性心血管自主神经测试建议

拓展阅读

科室

工具

服务

心血管指南

2021 EFAS/AAS/EAN共识声明：在可能导致短暂意识丧失情况下进行倾斜试验和其他激发性心血管自主神经测试建议

拓展阅读

2023 NICE 临床指南：超过16秒的短暂意识丧失(“昏厥”)

科室

工具

服务